Health Canada has authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus. The mRNA vaccine, called Nuvaxovid, has been reformulated to target the JN.1 subvariant of Omicron. It will replace the previous version of the protein-based vaccine, which targeted the XBB.1.5 subvariant of Omicron. Health Canada recently asked provinces and

The post Health Canada approves updated Novavax COVID-19 vaccine appeared first on Medicine Hat News.